disclaimer and use limitation
play

Disclaimer and Use Limitation THIS PRESENTATION AND ITS CONTENTS ARE - PowerPoint PPT Presentation

May 26, 2023 •589 likes •740 views

Disclaimer and Use Limitation THIS PRESENTATION AND ITS CONTENTS ARE CONFIDENTIAL AND ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, D IRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA (THE U.S.)

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Mesoscopic simulations of receptive lattices Limitation of deterministic approaches Limitation

Mesoscopic simulations of receptive lattices Limitation of deterministic approaches Limitation

Mesoscopic simulations of receptive lattices Limitation of deterministic approaches Limitation of deterministic approaches Continuous, deterministic models cant cope with: 1. Sensitivity to a very small number of molecules 2. Protein

1.14k views • 66 slides
Forum Shopping in Marine Casualty Cases by David McInnes, Partner Content: Limitation of

Forum Shopping in Marine Casualty Cases by David McInnes, Partner Content: Limitation of

Forum Shopping in Marine Casualty Cases by David McInnes, Partner Content: Limitation of liability conventions Introduction 1957 Brussels Limitation Convention 1976 London Convention on the Limitation of Liability for Maritime

1.08k views • 18 slides
Hot Loss Transfer Issues By By: : Kevin in S. S. Adams Feb Feb/2016 Introduction LIMITATION

Hot Loss Transfer Issues By By: : Kevin in S. S. Adams Feb Feb/2016 Introduction LIMITATION

Hot Loss Transfer Issues By By: : Kevin in S. S. Adams Feb Feb/2016 Introduction LIMITATION PERIOD / LACHES QUANTUM OF INDEMNITY MULTIPLE DEDUCTIBLES PERMITTED FAULT DETERMINATION RULE 9(4) ORDINARY RULES OF LAW Loss Transfer Limitation

332 views • 12 slides
Business Interest Limitation Working Group Meeting May 20, 2019 Meeting Agenda Meeting Agenda

Business Interest Limitation Working Group Meeting May 20, 2019 Meeting Agenda Meeting Agenda

Business Interest Limitation Working Group Meeting May 20, 2019 Meeting Agenda Meeting Agenda Purpose of the Meeting Federal Business Interest Limitation Tax Filings by Affiliated Groups Issue: Computing the Limitation for

600 views • 24 slides
Disclaimer This presentation contains statements that constitute forward looking statements

Disclaimer This presentation contains statements that constitute forward looking statements

L EADING V ERTICALLY I NTEGRATED G ENERIC P LAYER February 2018 Disclaimer This presentation contains statements that constitute forward looking statements including and without limitation, statements relating to the implementation of

608 views • 27 slides
Disclaimer This presentation contains statements that constitute forward looking statements

Disclaimer This presentation contains statements that constitute forward looking statements

Q3 FY16-17 E ARNINGS P RESENTATION 9 th February 2017 Disclaimer This presentation contains statements that constitute forward looking statements including and without limitation, statements relating to the implementation of strategic

723 views • 11 slides
PRESENTATION 1 Disclaimer This presentation contains forward-looking statements about Net

PRESENTATION 1 Disclaimer This presentation contains forward-looking statements about Net

NET HOLDING CORPORATE PRESENTATION 1 Disclaimer This presentation contains forward-looking statements about Net Holding A.S. and their respective subsidiaries and businesses. These include, without limitation, those concerning the strategy of

451 views • 42 slides
Corporate Presentation October 2019 Disclaimer This Presentation contains certain

Corporate Presentation October 2019 Disclaimer This Presentation contains certain

Corporate Presentation October 2019 Disclaimer This Presentation contains certain "forward-looking statements" including, without limitation, expectations, beliefs, plans and objectives regarding the timing and nature of estimated

366 views • 26 slides
Sept 27, 2013 shortform DISCLAIMER TSX-V: IDI Certain statements contained in this document,

Sept 27, 2013 shortform DISCLAIMER TSX-V: IDI Certain statements contained in this document,

P ORPHYRY & S KARN C OPPER -M OLYBDENUM -G OLD E XPLORATION TSX-V: IDI Sept 27, 2013 shortform DISCLAIMER TSX-V: IDI Certain statements contained in this document, including, without limitation, those concerning the economic outlook for

634 views • 26 slides
PRESENTATION November 2017 1 DISCLAIMER This presentation contains forward-looking statements

PRESENTATION November 2017 1 DISCLAIMER This presentation contains forward-looking statements

CORPORATE PRESENTATION November 2017 1 DISCLAIMER This presentation contains forward-looking statements about Net Holding A.S. and their respective subsidiaries and businesses. These include, without limitation, those concerning the strategy

445 views • 40 slides
CORPORATE PRESENTATION February 2018 1 DISCLAIMER This presentation contains forward-looking

CORPORATE PRESENTATION February 2018 1 DISCLAIMER This presentation contains forward-looking

CORPORATE PRESENTATION February 2018 1 DISCLAIMER This presentation contains forward-looking statements about Net Holding A.S. and their respective subsidiaries and businesses. These include, without limitation, those concerning the strategy

544 views • 38 slides
Junior lawyers professional indemnity seminar 4 June 2015 Section 14A of the Limitation Act

Junior lawyers professional indemnity seminar 4 June 2015 Section 14A of the Limitation Act

4/06/2015 Junior lawyers professional indemnity seminar 4 June 2015 Section 14A of the Limitation Act 1980 Theres No Limit? Niamh OReilly Extending the Limitation Period in Professional Negligence Claims Section 14A of the

574 views • 12 slides
Disabled and Over-65 Tax Limitation January 10, 2017 Purpose of Work Session Present

Disabled and Over-65 Tax Limitation January 10, 2017 Purpose of Work Session Present

Disabled and Over-65 Tax Limitation January 10, 2017 Purpose of Work Session Present Information on the Over 65 and Disabled Tax Limitation and estimated financial impacts 2 Tax Year 2016 Exemptions Exemptions Value Amount Tax Amount

119 views • 11 slides
2017 Results 19 March 2018 Disclaimer This presentation and its contents are This

2017 Results 19 March 2018 Disclaimer This presentation and its contents are This

2017 Results 19 March 2018 Disclaimer This presentation and its contents are This presentation is directed solely at persons To the extent available, any industry and without limitation, any statements preceded by, followed by or

494 views • 27 slides
ANNUAL RESULTS 31 DECEMBER 2019 DISCLAIMER By attending the meeting where this presentation is

ANNUAL RESULTS 31 DECEMBER 2019 DISCLAIMER By attending the meeting where this presentation is

ANNUAL RESULTS 31 DECEMBER 2019 DISCLAIMER By attending the meeting where this presentation is including, without limitation, those regarding the cannot be relied on as a guide to future performance. made, or by reading this document, you

420 views • 38 slides
Corporate Presentation Augu ugust 11, 11, 202 2020 Disclaimer This Presentation contains

Corporate Presentation Augu ugust 11, 11, 202 2020 Disclaimer This Presentation contains

Corporate Presentation Augu ugust 11, 11, 202 2020 Disclaimer This Presentation contains certain "forward-looking statements" including, without limitation, expectations, beliefs, plans and objectives regarding the timing and nature

631 views • 27 slides
Therapeutic Approaches to Chronic Kidney DiseaseBeyond the RAS Despite improvements in

Therapeutic Approaches to Chronic Kidney DiseaseBeyond the RAS Despite improvements in

Therapeutic Approaches to Chronic Kidney DiseaseBeyond the RAS Despite improvements in glycemia and BP control, and the efficacy of RAS blockade, a substantial number of patients will progress to ESRD. This finding is consistent

543 views • 12 slides
KDIGO Controversies Conference on Supportive Care Sara Davison & Gregorio T. Obrador

KDIGO Controversies Conference on Supportive Care Sara Davison & Gregorio T. Obrador

KDIGO Controversies Conference on Supportive Care Sara Davison & Gregorio T. Obrador Conference Co-Chairs Supportive Care Controversies Conference | December 6-8, 2013 | Mexico City, Mexico Controversies Conferences 2013

512 views • 38 slides
Strategic Health Care Network against CKD in Mexico (CKDSN) Federal Health Secretariat

Strategic Health Care Network against CKD in Mexico (CKDSN) Federal Health Secretariat

Strategic Health Care Network against CKD in Mexico (CKDSN) Federal Health Secretariat Innovation and Quality Subsecretariat Mexican Government 2010 Presented by: Librado de la Torre-Campos, MD Guillermo Garcia-Garcia, MD Background

684 views • 37 slides
A Systematic Review of Non- Pharmaceutical Interventions to Reduce Fatigue in Adults Receiving

A Systematic Review of Non- Pharmaceutical Interventions to Reduce Fatigue in Adults Receiving

A Systematic Review of Non- Pharmaceutical Interventions to Reduce Fatigue in Adults Receiving Hemodialysis Kim Schafer Astroth, PhD, RN Mennonite College of Nursing, Illinois State University, Normal, IL Cynthia L Russell, PhD, RN School of

591 views • 18 slides
East London Community Kidney Service Sally Hull, Neil Ashman, Sec Hoong, Nicola Thomas, Helen

East London Community Kidney Service Sally Hull, Neil Ashman, Sec Hoong, Nicola Thomas, Helen

East London Community Kidney Service Sally Hull, Neil Ashman, Sec Hoong, Nicola Thomas, Helen Rainey April 2017 What is the Problem? Fast rising ESRD rates in East London ever more people needing dialysis Haemodialysis rates per million

283 views • 15 slides
Nephrology Fellowship Program ACGME Accredited since 2012 Program Director: Dr. Roberto

Nephrology Fellowship Program ACGME Accredited since 2012 Program Director: Dr. Roberto

Methodist Dallas Medical Center Nephrology Fellowship Program ACGME Accredited since 2012 Program Director: Dr. Roberto Collazo-Maldonado collazor@dneph.com robertocollazomaldonado@mhd.com @collazor1 Nephrology Program Overview 2 Year

443 views • 18 slides
121 Tech Investment Hong Kong 13 th June 2019 BUILDING A GLOBAL DIAGNOSTICS BUSINESS ASX: PIQ

121 Tech Investment Hong Kong 13 th June 2019 BUILDING A GLOBAL DIAGNOSTICS BUSINESS ASX: PIQ

121 Tech Investment Hong Kong 13 th June 2019 BUILDING A GLOBAL DIAGNOSTICS BUSINESS ASX: PIQ DISCLAIMER This Presentation is provided by Proteomics International Laboratories Ltd (PILL, the Company). You should not rely upon anything in this

467 views • 15 slides
Chronic Kidney Disease & Mineral Bone Disorder: What are the drivers of disease? John

Chronic Kidney Disease & Mineral Bone Disorder: What are the drivers of disease? John

Mechanisms in chronic kidney disease Chronic Kidney Disease & Mineral Bone Disorder: What are the drivers of disease? John Cunningham University College London United Kingdom Chronic Kidney Disease & Mineral Bone Disorder what are

755 views • 28 slides

More recommend